NEW YORK (GenomeWeb) – Interleukin Genetics reported a 14 percent increase in total revenues year-over-year for the fourth quarter of fiscal year 2015.

For the three months ended Dec. 31, the Waltham, Massachusetts-based diagnostics firm said revenues increased to $365,648, up from $322,005 a year ago.

"We focused on developing and executing a significantly updated strategic and operational plan centered on the medical value of our genetic test, PerioPredict," Interleukin CEO Mark Carbeau said in a statement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.